ResearcherZhengzhou UniversityNo recent work listed

Yanpeng Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6520-7198; OpenAlex author ID A5100665103. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 2

Identification of a new pseudogenes/lncRNAs-hsa-miR-26b-5p-COL12A1 competing endogenous RNA network associated with prognosis of pancreatic cancer using bioinf… Co-author DOI 10.18632/aging.103709 ↗
Aspirin might reduce the incidence of pancreatic cancer: A meta-analysis of observational studies. Co-author DOI 10.1038/srep15460 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shilei Jing · 1 shared paper, 2020 · strength 0.15
- Paper Identification of a new pseudogenes/lncRNAs-hsa-miR-26b-5p-COL12A1 competing endogenous RNA network associated with pro… DOI 10.18632/aging.103709 ↗
Shusen Zheng · 1 shared paper, 2020 · strength 0.15
- Paper Identification of a new pseudogenes/lncRNAs-hsa-miR-26b-5p-COL12A1 competing endogenous RNA network associated with pro… DOI 10.18632/aging.103709 ↗
Rongtao Zhu · 1 shared paper, 2015 · strength 0.06
- Paper Aspirin might reduce the incidence of pancreatic cancer: A meta-analysis of observational studies. DOI 10.1038/srep15460 ↗
Yuling Sun · 1 shared paper, 2015 · strength 0.06
- Paper Aspirin might reduce the incidence of pancreatic cancer: A meta-analysis of observational studies. DOI 10.1038/srep15460 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.